|
Statement
| 1.Date of occurrence of the event:2022/07/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of
$374,319 thousands(expressed in NT dollars; unaudited), a consolidated
operating profit of $68,942 thousands, and a consolidated income
before tax of $103,049 thousands in June 2022; net income attributed to
stockholders of the company was $85,192 thousands; EPS is $0.34.
Year-to-date consolidated net sales was $2,201,947 thousands (in NT
dollars; unaudited), a consolidated operating profit was $546,228
thousands and consolidated income before tax was $640,223 thousands
until June 2022; year-to-date net income attributed to stockholders
of the company was $512,668 thousands; EPS is $2.06.
6.Countermeasures:None.
7.Any other matters that need to be specified:The numbers above are unaudited.
In term of the final net sales and profits, quarterly financial reports
audited by independent accountants will prevail.
|
